The bill amends the Public Health Code by adding a new section, 7333c, which mandates that pharmacists must dispense addiction medication promptly upon receiving a lawful order from a prescriber. It specifies that pharmacies are required to maintain a minimum stock of at least a two-week supply of addiction medication at all times. This legislation aims to ensure that patients have timely access to necessary medications for treating opioid use disorders.

Additionally, the bill defines key terms related to the dispensing of addiction medication. "Addiction medication" refers to FDA-approved controlled substances for opioid use disorder treatment, such as buprenorphine. The terms "undue delay" and "valid delay" are also clarified, with "undue delay" being defined as any delay that obstructs patient access, while "valid delay" pertains to delays that are part of standard pharmacy practices or regulatory requirements.

Statutes affected:
Senate Introduced Bill: 333.1101, 333.25211